Tag: 87M

  • Nuclera extends Series C funding to $87M to accelerate antibody engineering work

    Biotech company Nuclera has secured an additional $12 million in financing, bringing its total Series C funding to $87 million. The extension was led by Elevage Medical Technologies and Jonathan Milner, with participation from existing investors British Business Bank and GK Goh. Nuclera is focused on streamlining protein expression and purification workflows through its benchtop read more

    Written by

    dweetleapp
    Nuclera extends Series C funding to M to accelerate antibody engineering work